TY - JOUR
T1 - An autoregressive cross-lagged model unraveling co-occurring stimulant use and HIV
T2 - Results from a randomized controlled trial
AU - Lee, Ji Young
AU - Lee, Jae Eun
AU - Moskowitz, Judith T.
AU - Feaster, Daniel J.
AU - Neilands, Torsten B.
AU - Dilworth, Samantha E.
AU - Rodriguez, Allan
AU - Carrico, Adam W.
N1 - Funding Information:
This project was supported by the National Institute on Drug Abuse ( R01-DA033854 ; Carrico, Woods, and Moskowitz, PIs) and the National Institute of Mental Health ( K24-MH093225 ; Moskowitz, PI). Additional support for this project was provided by the University of California , San Francisco Center for AIDS Research’s Virology Core ( P30-AI027763 ; Volberding, PI), the Miami Center for AIDS Research ( P30-AI073961 ; Pahwa, PI), and the Center for HIV Research and Mental Health ( P30-MH116867 ; Safren, PI). This project was investigator initiated without directives from the funding sources.
Funding Information:
This project was supported by the National Institute on Drug Abuse (R01-DA033854; Carrico, Woods, and Moskowitz, PIs) and the National Institute of Mental Health (K24-MH093225; Moskowitz, PI). Additional support for this project was provided by the University of California, San Francisco Center for AIDS Research's Virology Core (P30-AI027763; Volberding, PI), the Miami Center for AIDS Research (P30-AI073961; Pahwa, PI), and the Center for HIV Research and Mental Health (P30-MH116867; Safren, PI). This project was investigator initiated without directives from the funding sources.
Publisher Copyright:
© 2021 Elsevier B.V.
PY - 2021/8/1
Y1 - 2021/8/1
N2 - Background: Evidence-based interventions are needed to address the use of stimulants such as methamphetamine as a driver of onward HIV transmission and faster clinical HIV progression among sexual minority men. Prior randomized controlled trials with people living with HIV who use substances indicate that financial incentives provided during contingency management (CM) are effective for achieving short-term reductions in stimulant use and HIV viral load. However, the benefits of CM are often not maintained after financial incentives for behavior change end. Purpose: Data from a recently completed randomized controlled trial with 110 sexual minority men living with HIV who use methamphetamine was leveraged to examine mediators of the efficacy of a positive affect intervention for extending the benefits of CM. Methods: An autoregressive cross-lagged model was fit to determine if reductions in HIV viral load were mediated by intervention-related increases in positive affect and decreases in stimulant use measured in four waves over 15 months. Results: Higher baseline positive affect predicted significantly lower self-reported stimulant use immediately following the 3-month CM intervention period, even after controlling for self-reported stimulant use at baseline. Moreover, decreased stimulant use emerged as an independent predictor of long-term reductions HIV viral load at 15 months, even after adjusting for HIV viral load at baseline and the residual effect of the positive affect intervention. Conclusions: Findings underscore the importance of durable reductions in stimulant use as a primary intervention target that is essential for optimizing the clinical and public health benefits of HIV treatment as prevention.
AB - Background: Evidence-based interventions are needed to address the use of stimulants such as methamphetamine as a driver of onward HIV transmission and faster clinical HIV progression among sexual minority men. Prior randomized controlled trials with people living with HIV who use substances indicate that financial incentives provided during contingency management (CM) are effective for achieving short-term reductions in stimulant use and HIV viral load. However, the benefits of CM are often not maintained after financial incentives for behavior change end. Purpose: Data from a recently completed randomized controlled trial with 110 sexual minority men living with HIV who use methamphetamine was leveraged to examine mediators of the efficacy of a positive affect intervention for extending the benefits of CM. Methods: An autoregressive cross-lagged model was fit to determine if reductions in HIV viral load were mediated by intervention-related increases in positive affect and decreases in stimulant use measured in four waves over 15 months. Results: Higher baseline positive affect predicted significantly lower self-reported stimulant use immediately following the 3-month CM intervention period, even after controlling for self-reported stimulant use at baseline. Moreover, decreased stimulant use emerged as an independent predictor of long-term reductions HIV viral load at 15 months, even after adjusting for HIV viral load at baseline and the residual effect of the positive affect intervention. Conclusions: Findings underscore the importance of durable reductions in stimulant use as a primary intervention target that is essential for optimizing the clinical and public health benefits of HIV treatment as prevention.
KW - Contingency management
KW - Men who have sex with Men
KW - Methamphetamine
KW - Positive affect
KW - Treatment as prevention
UR - http://www.scopus.com/inward/record.url?scp=85108016135&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85108016135&partnerID=8YFLogxK
U2 - 10.1016/j.drugalcdep.2021.108752
DO - 10.1016/j.drugalcdep.2021.108752
M3 - Article
C2 - 34144507
AN - SCOPUS:85108016135
SN - 0376-8716
VL - 225
JO - Drug and Alcohol Dependence
JF - Drug and Alcohol Dependence
M1 - 108752
ER -